Bansal Drugs Private Limited - Company Profile

It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1995.
1995 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Bansal Drugs Private Limited

Bansal Drugs Private Limited, a active private limited company, was established on 31 March 1995 in Uttar Pradesh, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231UP1995PTC017799. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Neeru Agarwal (Director), Nishant Raman (Director). Past directors included Rajendra Kumar, Gopal Dass. It holds ₹3.18 Cr open charges and ₹1.17 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, Uttar Pradesh, 250002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231UP1995PTC017799

  • Registration Number

    017799

  • Incorporation Date

    31 March 1995

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.18 Cr
  • Satisfied Charges ₹ 1.17 Cr
  • Revenue Growth **** 26.52%
  • Profit Growth **** 2.66%
  • Ebitda **** -402.09%
  • Net Worth 3.34%
  • Total Assets **** 13.60%
Company report

Bansal Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bansal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bansal Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Neeru Agarwal Director 25 Oct 2022 Current
Nishant Raman Director 16 Mar 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Oct 2022 Past
Pramod Abcsdd Director 16 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bansal Drugs.

Bansal Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.52% increase. The company also saw a slight improvement in profitability, with a 2.66% increase in profit. The company's net worth moved up by a moderate rise of 3.34%.

Bansal Drugs revenue growth over time
Bansal Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 26.52%
*******
*******
*******
*******
Revenue from Operations
*******
 26.58%
*******
*******
*******
*******
Total Assets
*******
 13.60%
*******
*******
*******
*******
Profit or Loss
*******
 2.66%
*******
*******
*******
*******
Net Worth
*******
 3.34%
*******
*******
*******
*******
EBITDA
*******
 -402.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bansal Drugs?

Unlock access to Bansal Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹31,817,000.00

Satisfied Charges

₹11,700,000.00

Charges Breakdown by Lending Institutions
  • Others : 3.18 Cr
Latest Charge Details
Date Lender Amount Status
21 Feb 2015 Others ₹3.18 Cr Open
28 Mar 2011 Indian Overseas Bank ₹5.00 M Satisfied
18 Dec 2001 Union Bank Of India ₹5.00 M Satisfied
01 Mar 1996 Union Bank Of India ₹1.70 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Bansal Drugs?

Unlock and access historical data on people associated with Bansal Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bansal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bansal Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bansal Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Bansal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Bansal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Charges

    The activity A charge with Others of Rs. 31.82 M registered on 21 Feb 2015 with Charge ID 10569070 was modified on 29 May 2024. was completed.

  • Director Appointment

    Neeru Agarwal was appointed as a Director was appointed as a Director on 25 Oct 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Director Appointment

    Nishant Raman was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 10 years 11 months . was recorded as a recent event.

  • Charges

    The activity A charge registered on 28 Mar 2011 via Charge ID 10280907 with Indian Overseas Bank was fully satisfied on 27 Feb 2015. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bansal Drugs Private Limited?

The CIN of Bansal Drugs Private Limited is U24231UP1995PTC017799.

Where is Bansal Drugs Private Limited headquartered?

Bansal Drugs Private Limited is headquartered at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, Uttar Pradesh, 250002.

When was Bansal Drugs Private Limited incorporated?

Bansal Drugs Private Limited was incorporated on 31 March 1995.

Who are the current directors of Bansal Drugs Private Limited?

The current directors of Bansal Drugs Private Limited are

What is the primary industry of Bansal Drugs Private Limited?

The primary industry of Bansal Drugs Private Limited is Trade.

Is Bansal Drugs Private Limited a listed company?

Bansal Drugs Private Limited is unlisted.

What is the capital structure of Bansal Drugs Private Limited?

The authorized capital of Bansal Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Bansal Drugs Private Limited?

The compliance status of Bansal Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available